Seres Therapeutics Presents Phase Ill Results of SER-109 for Recurrent C. Difficile Infection at the Digestive Disease Week (DDW) Annual Meeting : vimarsana.com

Seres Therapeutics Presents Phase Ill Results of SER-109 for Recurrent C. Difficile Infection at the Digestive Disease Week (DDW) Annual Meeting

Seres Therapeutics Presents Phase Ill Results of SER-109 for Recurrent C. Difficile Infection at the Digestive Disease Week (DDW) Annual Meeting

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Matthew Henn , Kristin Ainsworth , Exchange Commission , Seres Therapeutics Inc , Drug Administration , Nasdaq , Wall Street , Disease Week , Chief Scientific Officer , Biologics License Application , Chief Medical Officer , Fatty Acid Production , New England Journal , Orphan Drug , Breakthrough Therapy , Infection Protection , Private Securities Litigation Reform Act , Quarterly Report ,